M&A Deal Summary

Alfa Aesar & Co KG Acquires Biomedical Technologies

On September 16, 2013, Alfa Aesar & Co KG acquired medical products company Biomedical Technologies

Acquisition Highlights
  • This is Alfa Aesar & Co KG’s 1st transaction in the Medical Products sector.
  • This is Alfa Aesar & Co KG’s 1st transaction in the United States.
  • This is Alfa Aesar & Co KG’s 1st transaction in Massachusetts.

M&A Deal Summary
Date 2013-09-16
Target Biomedical Technologies
Sector Medical Products
Buyer(s) Alfa Aesar & Co KG
Deal Type Add-on Acquisition

Target

Biomedical Technologies

Stoughton, Massachusetts, United States
website
BTI has been manufacturing life science research products for more than 30 years, with a commitment to its customers of technology, quality and value. Its product line includes specialty proteins, cell culture additives and highly specific immunoassay tools, which Alfa Aesar will continue to build upon as it expands its portfolio of unique biochemical products for the researcher.

Search 193,502 Deals Now

SEARCH BY

  • Buyer Type (PE or Strategic)
  • Deal Size ($10M to $10B+)
  • Sector (60 Sectors)
  • Deal Type
  • Geography
  • & More

Try For Free 7-Day Free Trial

Buyer(S) 1

Buyer

Alfa Aesar & Co KG

Karlsruhe, Germany

website

Category Company
Sector Chemicals
Employees480
Revenue 78M GBP (2014)
DESCRIPTION

Alfa Aesar GmbH & Co KG is a manufacturer and supplier of research chemicals.

DEAL STATS #
Overall 1 of 1
Sector (Medical Products) 1 of 1
Type (Add-on Acquisition) 1 of 1
State (Massachusetts) 1 of 1
Country (United States) 1 of 1
Year (2013) 1 of 1
Mergr

Product

Company

Legal